IP Library Patent Application 18105755
Patent Application
App. No. 18/105,755

SELECTIVE HIGH FREQUENCY SPINAL CORD MODULATION FOR INHIBITING PAIN WITH REDUCED SIDE EFFECTS, AND ASSOCIATED SYSTEMS AND METHODS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/105,755
Abstract

Selective high-frequency spinal chord modulation for inhibiting pain with reduced side affects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal chord region to address low back pain without creating unwanted sensory and/or motor side affects. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.

Claims (33)

1 - 137 . (canceled)

138 . A method for treating a patient, comprising:

programming a signal generator to deliver an electrical signal to the patient's dorsal horn and/or dorsal column via at least one implantable signal delivery device; and

wherein the electrical signal has sequential bi-phasic pulses with a pulse width in a pulse width range from 10 microseconds to 333 microseconds and does not create paresthesia in the patient.

139 . The method of claim 138 wherein the pulses form a bi-phasic square wave.

140 . The method of claim 138 wherein the pulse width range is from 25 microseconds to 166 microseconds.

141 . The method of claim 138 wherein the pulse width range is from 33 microseconds to 100 microseconds.

142 . The method of claim 138 wherein the pulse width range is from 30 microseconds to 35 microseconds.

143 . The method of claim 138 wherein at least a portion of the electrical signal has a current amplitude in a range from 0.5 mA to 10 mA.

144 . The method of claim 138 wherein at least a portion of the electrical signal has a current amplitude in a range from 0.5 mA to 4 mA.

145 . The method of claim 138 wherein the signal generator is implantable in the patient.

146 . The method of claim 138 wherein the signal generator is external to the patient.

147 . The method of claim 138 wherein programming includes programming the signal generator to deliver the electrical signal to the patient's dorsal horn.

148 . The method of claim 138 wherein programming includes programming the signal generator to deliver the electrical signal to the patient's dorsal column.

149 . The method of claim 138 wherein programming includes programming the signal generator to deliver the electrical signal to the patient's epidural space.

150 . The method of claim 138 wherein programming includes programming the signal generator to deliver the electrical signal to reduce patient pain.

151 . A method for treating a patient, comprising:

programming a signal generator to deliver an electrical signal to the patient's dorsal horn and/or dorsal column via at least one implantable signal delivery device; and

wherein the electrical signal has sequential bi-phasic pulses having a pulse width in a pulse width range from 10 microseconds to 333 microseconds and an amplitude that does not create paresthesia in the patient.

152 . The method of claim 151 wherein the pulses form a bi-phasic square wave.

153 . The method of claim 151 wherein the pulse width range is from 30 microseconds to 35 microseconds.

154 . The method of claim 151 wherein at least a portion of the electrical signal has a current amplitude in a range from 0.5 mA to 10 mA.

155 . The method of claim 151 wherein at least a portion of the electrical signal has a current amplitude in a range from 0.5 mA to 4 mA.

156 . The method of claim 151 wherein the signal generator is implantable in the patient.

157 . The method of claim 151 wherein the signal generator is external to the patient.

158 . The method of claim 151 wherein programming includes programming the signal generator to deliver the electrical signal to the patient's dorsal horn.

159 . The method of claim 151 wherein programming includes programming the signal generator to deliver the electrical signal to the patient's dorsal column.

160 . The method of claim 151 wherein programming includes programming the signal generator to deliver the electrical signal to reduce or eliminate patient pain.

161 . A method for treating a patient, comprising:

delivering an electrical signal to the patient's dorsal horn and/or dorsal column via at least one implantable signal delivery device; and

wherein the electrical signal has sequential bi-phasic pulses with a pulse width in a pulse width range from 10 microseconds to 333 microseconds and does not create paresthesia in the patient.

162 . The method of claim 161 wherein delivering the electrical signal includes delivering the electrical signal to a vertebral location within a range from T9-T12.

163 . The method of claim 161 wherein delivering the electrical signal includes delivering the electrical signal to a vertebral location within a range from T9-T10.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2023
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.; PARKER, JON; CHITRE, YOUGANDH; PARK, SANGSOO WESLEY; THACKER, JAMES R.
To: NEVRO CORP.
Reel/Frame 062590/0653 →